{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:51Z","timestamp":1789858131625,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10067-008-0995-9","type":"journal-article","created":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T09:24:09Z","timestamp":1220347449000},"page":"129-137","source":"Crossref","is-referenced-by-count":116,"title":["Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study"],"prefix":"10.1007","volume":"28","author":[{"given":"Norman","family":"Ilowite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilynn","family":"Punaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Harville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Nien","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Bevirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Aras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,3]]},"reference":[{"key":"995_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.autrev.2005.09.011","volume":"5","author":"AT Borchers","year":"2006","unstructured":"Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5:279\u2013298","journal-title":"Autoimmun Rev"},{"key":"995_CR2","unstructured":"Taylor J, Erlandson D (2001) Pediatric rheumatic diseases. In: Clinical care of the rheumatic diseases. American College of Rheumatology, Atlanta, GA"},{"key":"995_CR3","first-page":"367","volume":"17","author":"A Gare","year":"1999","unstructured":"Gare A (1999) Juvenile arthritis\u2014who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 17:367\u2013374","journal-title":"Clin Exp Rheumatol"},{"key":"995_CR4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/art.1780261006","volume":"26","author":"SR Towner","year":"1983","unstructured":"Towner SR, Michet CJ Jr, O'Fallon WM, Nelson AM (1983) The epidemiology of juvenile arthritis in Rochester, Minnesota 1960\u20131979. Arthritis Rheum 26:1208\u20131213","journal-title":"Arthritis Rheum"},{"key":"995_CR5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.1780401108","volume":"40","author":"CJ Henderson","year":"1997","unstructured":"Henderson CJ, Cackwell GD, Specker BL, Sierra RI, Wilmott RW, Campaigne BN, Lovell DJ (1997) Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 40:1967\u20131975","journal-title":"Arthritis Rheum"},{"key":"995_CR6","first-page":"309","volume":"28","author":"K Kotaniemi","year":"2001","unstructured":"Kotaniemi K, Aho K, Kotaniemi A (2001) Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 28:309\u2013312","journal-title":"J Rheumatol"},{"key":"995_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/rheumatology\/keh030","volume":"43","author":"MG Sawyer","year":"2004","unstructured":"Sawyer MG, Whitham JN, Roberton DM, Taplin JE, Varni JW, Baghurst PA (2004) The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatology (Oxford) 43:325\u2013330","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/rheumatology\/keg395","volume":"42","author":"RR Welbury","year":"2003","unstructured":"Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Marshall NJ, Foster HE (2003) Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis. Rheumatology (Oxford) 42:1445\u20131451","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR9","first-page":"225","volume":"11","author":"U Feige","year":"1989","unstructured":"Feige U, Karbowski A, Rordorf-Adam C, Pataki A (1989) Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint. Int J Tissue React 11:225\u2013238","journal-title":"Int J Tissue React"},{"key":"995_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00541245","volume":"2","author":"A Fontana","year":"1982","unstructured":"Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G (1982) Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 2:49\u201353","journal-title":"Rheumatol Int"},{"key":"995_CR11","first-page":"1349","volume":"32","author":"N Saxena","year":"2005","unstructured":"Saxena N, Aggarwal A, Misra R (2005) Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J Rheumatol 32:1349\u20131353","journal-title":"J Rheumatol"},{"key":"995_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1902\/jop.2007.060135","volume":"78","author":"A Havemose-Poulsen","year":"2007","unstructured":"Havemose-Poulsen A, Sorensen LK, Bendtzen K, Holmstrup P (2007) Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 78:475\u2013492","journal-title":"J Periodontol"},{"key":"995_CR13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01451007","volume":"17","author":"N Kutukculer","year":"1998","unstructured":"Kutukculer N, Caglayan S, Aydogdu F (1998) Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 17:288\u2013292","journal-title":"Clin Rheumatol"},{"key":"995_CR14","first-page":"2359","volume":"21","author":"KL Madson","year":"1994","unstructured":"Madson KL, Moore TL, Lawrence JM 3rd, Osborn TG (1994) Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 21:2359\u20132363","journal-title":"J Rheumatol"},{"key":"995_CR15","first-page":"515","volume":"11","author":"T Geiger","year":"1993","unstructured":"Geiger T, Towbin H, Cosenti-Vargas A, Zingel O, Arnold J, Rordorf C, Glatt M, Vosbeck K (1993) Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA\/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol 11:515\u2013522","journal-title":"Clin Exp Rheumatol"},{"key":"995_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10141","volume":"46","author":"S Cohen","year":"2002","unstructured":"Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D (2002) Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:614\u2013624","journal-title":"Arthritis Rheum"},{"key":"995_CR17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","volume":"63","author":"SB Cohen","year":"2004","unstructured":"Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63:1062\u20131068","journal-title":"Ann Rheum Dis"},{"key":"995_CR18","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/art.10578","volume":"46","author":"G Nuki","year":"2002","unstructured":"Nuki G, Bresnihan B, Bear MB, McCabe D (2002) Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:2838\u20132846","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"995_CR19","first-page":"S437","volume":"50","author":"P Irigoyen","year":"2004","unstructured":"Irigoyen P, Olson J, Hom C, Ilowite NT (2004) Treatment of systemic onset juvenile rheumatoid arthritis with anakinra [abstract]. Arthritis Rheum 50(suppl):S437\u2013438","journal-title":"Arthritis Rheum"},{"key":"995_CR20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479\u20131486","journal-title":"J Exp Med"},{"key":"995_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1345\/aph.10123","volume":"35","author":"CJ Johnson","year":"2001","unstructured":"Johnson CJ, Reilly KM, Murray KM (2001) Etanercept in juvenile rheumatoid arthritis. Ann Pharmacother 35:464\u2013471","journal-title":"Ann Pharmacother"},{"key":"995_CR22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202\u20131209","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"995_CR23","first-page":"S153","volume":"43","author":"B Yang","year":"2000","unstructured":"Yang B, Frazier J, McCabe J, Young J (2000) Population pharmacokinetics of recombinant interleukin-1 receptor antagonist (anakinra) in subjects with rheumatoid arthritis (RA) [abstract]. Arthritis Rheum 43(suppl):S153","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"995_CR24","first-page":"161","volume":"60","author":"B Yang","year":"2001","unstructured":"Yang B, Frazier J, McCabe J, Young J (2001) Population pharmacokinetics (PK) of anakinra in subjects with rheumatoid arthritis RA [abstract]. Ann Rheum Dis 60(suppl 1):161","journal-title":"Ann Rheum Dis"},{"key":"995_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2001.23701","volume":"30","author":"B Bresnihan","year":"2001","unstructured":"Bresnihan B (2001) The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30:17\u201320","journal-title":"Semin Arthritis Rheum"},{"key":"995_CR26","unstructured":"WHO (World Health Organization) Toxicity Criteria (2008) Available via http:\/\/www.fda.gov\/cder\/cancer\/toxicityframe.htm . Cited February 6, 2008"},{"key":"995_CR27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard.2005.048371","volume":"65","author":"RM Fleischmann","year":"2006","unstructured":"Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B (2006) Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 65:1006\u20131012","journal-title":"Ann Rheum Dis"},{"key":"995_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.21852","volume":"55","author":"KL Shaw","year":"2006","unstructured":"Shaw KL, Southwood TR, Duffy CM, McDonagh JE (2006) Health-related quality of life in adolescents with juvenile idiopathic arthritis. Arthritis Rheum 55:199\u2013207","journal-title":"Arthritis Rheum"},{"key":"995_CR29","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287\u20132293","journal-title":"Arthritis Rheum"},{"key":"995_CR30","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52:3403\u20133412","journal-title":"Arthritis Rheum"},{"key":"995_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2005.041640","volume":"65","author":"EH Giannini","year":"2006","unstructured":"Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich EC, Reiff AO (2006) A phase 4 registry of etanercept in children with juvenile rheumatoid arthritis. [abstract THU0456]. Ann Rheum Dis 65:253","journal-title":"Ann Rheum Dis"},{"key":"995_CR32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.10710","volume":"48","author":"DJ Lovell","year":"2003","unstructured":"Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218\u2013226","journal-title":"Arthritis Rheum"},{"key":"995_CR33","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","volume":"54","author":"DJ Lovell","year":"2006","unstructured":"Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 54:1987\u20131994","journal-title":"Arthritis Rheum"},{"key":"995_CR34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerre","year":"2008","unstructured":"Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loet X, Sibilia J (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302\u2013308","journal-title":"Ann Rheum Dis"},{"key":"995_CR35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/ken030","volume":"47","author":"V Ohlsson","year":"2008","unstructured":"Ohlsson V, Baildam E, Foster H, Jandial S, Pain C, Strike H, Ramanan AV (2008) Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford) 47:555\u2013556","journal-title":"Rheumatology (Oxford)"},{"key":"995_CR36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S, Delfino L, Ferlito F, Pelagatti MA, Caroli F, Buoncompagni A, Viola S, Loy A, Sironi M, Vecchi A, Ravelli A, Martini A, Rubartelli A (2008) The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 58:1505\u20131515","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0995-9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T10:59:41Z","timestamp":1554634781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-0995-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-0995-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,3]]}}}